Who owns the CORRECTSEQUENCE THERAPEUTICS trademark?

The CORRECTSEQUENCE THERAPEUTICS trademark is owned by CorrectSequence Therapeutics Co., Ltd.

What class is the CORRECTSEQUENCE THERAPEUTICS trademark registered in?

The CORRECTSEQUENCE THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

What is the serial number for CORRECTSEQUENCE THERAPEUTICS?

The USPTO serial number for CORRECTSEQUENCE THERAPEUTICS is 97222611.

What is the registration number for CORRECTSEQUENCE THERAPEUTICS?

CORRECTSEQUENCE THERAPEUTICS is registered under USPTO registration number 0.

COR

USPTO Trademark Record

ABANDONED

CORRECTSEQUENCE THERAPEUTICS

SN 97222611·Reg 0·Filed Jan 17, 2022

Owner CorrectSequence Therapeutics Co., Ltd

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CORRECTSEQUENCE THERAPEUTICS (Serial No. 97222611), Registration No. 0, is a abandoned US trademark filed on Jan 17, 2022 by CorrectSequence Therapeutics Co., Ltd. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Revival window: October 31, 202624 days remaining

Mark Intelligence

CORRECTSEQUENCE THERAPEUTICS (Reg. #0) is an abandoned US trademark that was filed in 2022 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 17, 2022

SERIAL

97222611

REG#

Owner

Applicant

CorrectSequence Therapeutics Co., Ltd

Entity

Corporation

Address

Room 207, No. 6 Building, 99 Haike Road, Pudong District, Shanghai, 200120

Country

Attorney

NameNicholas B. Hawkins

Law firm

Nicholas B. Hawkins WOMBLE BOND DICKINSON (US) LLP

Address

100 LIGHT STREET, 26TH FLOOR, BALTIMORE, MD 21202, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJan 17, 2022

Serial Number97222611

Registration No.0

Status DateAug 31, 2026

Published for OppositionMay 30, 2023

Mark TypeStandard characters

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

ABANDONMENT - NO USE STATEMENT FILED

Aug 31, 2026

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 31, 2026

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 02, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 01, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

May 01, 2026

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Nov 28, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Nov 27, 2025

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 28, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 FILED

Jun 27, 2025

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Jun 27, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 GRANTED

Jun 27, 2025

SOU EXTENSION 4 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 30, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Dec 30, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Dec 30, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 30, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 24, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 19, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jul 19, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jul 19, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 27, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 25, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 25, 2024

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 25, 2024

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 25, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 30, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 30, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 10, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 24, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 22, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 21, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 21, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Oct 28, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 28, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 28, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 25, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 21, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 20, 2022

NEW APPLICATION ENTERED

CORRECTSEQUENCE THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by CorrectSequence Therapeutics Co., Ltd

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Nicholas B. Hawkins

Resources

Company